20170406 Telix Logo.png
Telix Progresses Novel Lung and Ovarian Cancer Theranostic APOMAB®
August 16, 2021 20:03 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia and ADELAIDE, Australia, Aug. 17, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) today announces it has extended its previously...
20170406 Telix Logo.png
Telix’s TLX66 in Phase II Academic Study of Pediatric Leukemia
August 16, 2021 19:55 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia and LONDON , Aug. 17, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the London-based Great Ormond Street Hospital...
20170406 Telix Logo.png
Mr. Ryoichi Tanaka Joins Telix Japan as Chief Operating Officer
August 05, 2021 18:14 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia and KYOTO Japan, Aug. 05, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) is pleased to announce that Mr. Ryoichi Tanaka has joined the...
20170406 Telix Logo.png
Ms. Helen Hovenga Joins Telix as Chief People Officer
August 03, 2021 17:48 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) is pleased to announce that Ms. Helen Hovenga has joined the Telix executive...
20170406 Telix Logo.png
Kyahn Williamson Joins Telix to Lead Corporate Communications and Investor Relations
July 11, 2021 18:40 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia, July 11, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) is pleased to announce that Ms. Kyahn Williamson has joined the Telix...
20170406 Telix Logo.png
First Patient Dosed in Clinical Study of TLX250-CDx in Bladder Cancer
June 22, 2021 19:22 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia, June 22, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) today announces that a first patient has been dosed in a Phase I study of...
20170406 Telix Logo.png
Telix to Present at the 2021 Jefferies Virtual Healthcare Conference
June 01, 2021 08:00 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia and NEW YORK, June 01, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that Chief Executive Officer, Dr. Christian...
20170406 Telix Logo.png
First Patient Dosed in Japanese Prostate Cancer Imaging Study
May 24, 2021 21:04 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia and KYOTO, Japan, May 25, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the first patient has been dosed in a...
20170406 Telix Logo.png
TLX66 Meets Study Objectives in Patients with AL Amyloidosis
May 24, 2021 20:59 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia and SOUTHAMPTON, United Kingdom, May 25, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the Company’s bone marrow...
20170406 Telix Logo.png
Telix Pharmaceuticals Appoints Mr. Richard Valeix as EMEA President
May 02, 2021 19:15 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia and HERSTAL, Belgium, May 02, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that Mr. Richard Valeix has joined the Telix...